Size-dependent gold nanoparticle interaction at nano–micro interface using both monolayer and multilayer (Tissue-Like) Cell models

Nano-Micro Letters

Volumn 8, Issue 1, 2016, Pages 44-53

  Yohan, Darren ^a   Cruje, Charmainne ^a   Lu, Xiaofeng ^b   Chithrani, Devika B ^a,b  

^a RYERSON UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Gold nanoparticles; Hyper spectral imaging; Multilayer cellular structures; Size dependence; Tissue penetration

Indexed keywords

BLOOD VESSELS; CELL CULTURE; CELLS; CELLULAR AUTOMATA; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG DOSAGE; FIBER OPTIC SENSORS; METAL NANOPARTICLES; MONOLAYERS; MULTILAYERS; RADIOTHERAPY; SPECTROSCOPY; TUMORS;

CELLULAR STRUCTURE; EXTRACELLULAR MATRICES; GOLD NANOPARTICLES (GNPS); HYPERSPECTRAL; MONOLAYER CELL CULTURE; NANOPARTICLE INTERACTION; SIZE DEPENDENCE; TISSUE PENETRATIONS;

GOLD NANOPARTICLES;

EID: 84979300126     PISSN: 23116706     EISSN: 21505551     Source Type: Journal    
DOI: 10.1007/s40820-015-0060-6     Document Type: Article

References (39)

1. D. Yohan, B.D. Chithrani, Applications of nanoparticles in nanomedicine. J. Biomed. Nanotechnol. 10(9), 2371-2392 (2014). doi:10.1166/jbn.2014.2015
2. S. Shrivastava, D. Dash, Label-free colorimetric estimation of proteins using nanoparticles of silver. Nano Micro Lett. 2(3), 164-168 (2010). doi:10.5101/nml.v2i3.p164-168
3. B.D. Chithrani, W.C.W. Chan, Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7(6), 1542-1550 (2007). doi:10.1021/nl070363y
4. B.D. Chithrani, A.A. Ghazani, W.C.W. Chan, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006). doi:10.1021/ nl052396o
5. R. Chouikrat, A. Seve, R. Vanderesse, H. Benachour, M. Barberi-Heyob, S. Richeter, L. Raehm, J.O. Durand, M. Verelst, C. Frochot, Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr. Med. Chem. 19(6), 781-792 (2012). doi:10.2174/092986712799034897
6. A.M. Alkilany, C.J. Murphy, Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res. 12(7), 2313-2333 (2010). doi:10.1007/s11051-010-9911-8
7. L.A. Liotta, Tumor invasion and metastases-role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 46(1), 1-7 (1986)
8. P.A. Netti, D.A. Berk, M.A. Swartz, A.J. Grodzinsky, R.K. Jain, Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60(9), 2497-2503 (2000)
9. T.T. Goodman, P.L. Olive, S.H. Pun, Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int. J. Nanomed. 2(2), 265-274 (2007)
10. D. Yohan, C. Cruje, X. Lu, B.D. Chithrani, Elucidating the uptake and distribution of nanoparticles in solid tumors via a multilayered cell culture model. Nano Micro Lett. 7(2), 127-137 (2015). doi:10.1007/s40820-014-0025-1
11. R. Grantab, S. Sivananthan, I.F. Tannock, The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res. 66(2), 1033-1039 (2006). doi:10.1186/1471-2407-12-214
12. R.K. Jain, Delivery of molecular and cellular medicine to solid tumors. J. Control. Rel. 53(1-3), 49-67 (1998). doi:10.1016/ S0168-3659(97)00237-X
13. P.K.J. Kuppen, M.M. van der Eb, L.E. Jonges, M. Hagenaars, M.E. Hokland, U. Nannmark et al., Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem. Cell Biol. 115(1), 67-72 (2001). doi:10.1007/ s004180000224
14. M.F. Flessner, J. Choi, K. Credit, R. Deverkadra, K. Henderson, Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clin. Cancer Res. 11(8), 3117-3125 (2005). doi:10.1158/ 1078-0432.CCR-04-2332
15. R.M. Phillips, P.M. Loadman, B.P. Cronin, Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br. J. Cancer 77(12), 2112-2119 (1998). doi:10.1038/bjc.1998.355
16. A.I. Minchinton, I.F. Tannock, Drug penetration in solid tumours. Nat. Rev. Cancer 6(8), 583-592 (2006). doi:10.1038/nrc1893
17. A.I. Minchinton, K.R. Wendt, K.A. Clow, K.H. Fryer, Multilayers of cells growing on a permeable support. An in vitro tumour model. Acta Oncol. 36(1), 13-16 (1997). doi:10.3109/ 02841869709100724
18. R.H. Thomlinson, L.H. Gray, The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9(4), 539-549 (1955). doi:10.1038/bjc.1955.55
19. R.K. Jain, Transport of molecules, particles, and cells in solid tumors. Annu. Rev. Biomed. Eng. 1, 241-263 (1999). doi:10. 1146/annurev.bioeng.1.1.241
20. S. Ramanujan, A. Pluen, T.D. McKee, E.B. Brown, Y. Boucher, R.K. Jain, Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys. J. 83(3), 1650-1660 (2002). doi:10.1016/S0006-3495(02)73933-7
21. T. Stylianopoulos, M.Z. Poh, N. Insin, M.G. Bawendi, D. Fukumura, L.L. Munn, R.K. Jain, Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys. J. 99, 1342-1349 (2010). doi:10.1016/j.bpj.2010. 06.016
22. T. Betancourt, B. Brown, L. Brannon-Peppas, Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine 2(2), 219-232 (2007). doi:10.2217/17435889.2.2.219
23. H. Lee, S. Park, J.B. Kim, J. Kim, H. Kim, Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis-resistant cancer cells. Cancer Lett. 332(1), 110-119 (2013). doi:10. 1016/j.canlet.2013.01.021
24. U. Benbow, M.P. Schoenermark, K.A. Orndorff, A.L. Givan, C.E. Brinckerhoff, Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by alltrans retinoic acid. Clin. Exp. Metastasis 17(3), 231-238 (1999). doi:10.1023/A:1006639214618
25. J.Y. Pille, C. Denoyelle, J. Varet, J.R. Bertrand, J. Soria et al., Anti-rhoa and anti-rhoc sirnas inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol. Ther. 11(2), 267-274 (2005). doi:10.1016/j.ymthe.2004.08. 029
26. W. Bursch, A. Ellinger, H. Kienzl, L. To¨ro¨k, S. Pandey, M. Sikorska, R. Walker, R.S. Hermann, Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17(8), 1595-1607 (1996). doi:10.1093/carcin/17.8. 1595
27. C.Y. Hsieh, R.C. Santell, S.Z. Haslam, W.G. Helferich, Estrogenic effects of genistein on the growth of estrogen receptorpositive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58(17), 3833-3838 (1998)
28. T.T. Wang, J.M. Phang, Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55(12), 2487-2489 (1995)
29. G. Frens, Controlled nucleation for the particle size in monodisperse gold suspensions. Nature 241, 20-22 (1973). doi:10.1038/physci241020a0
30. D.S. Cowan, K.O. Hicks, W.R. Wilson, Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br. J. Cancer Suppl. 27(2), 28-31 (1996)
31. I.F. Tannock, C.M. Lee, J.K. Tunggal, D.S. Cowan, M.J. Egorin, Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin. Cancer Res. 8(3), 878-884 (2002)
32. K.O. Hicks, Y. Fleming, B.G. Siim, C.J. Koch, W.R. Wilson, Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer model. Int. J. Radiat. Oncol. Biol. Phys. 42(3), 641-649 (1998). doi:10.1016/ S0360-3016(98)00268-5
33. W.R. Wilson, K.O. Hicks, Measurement of extravascular drug diffusion in multicellular layers. Br. J. Cancer 79(9-10), 1623-1626 (1999)
34. M. Neshatian, S. Chung, D. Yohan, C. Yang, D.B. Chithrani, Uptake of gold nanoparticles in breathless (hypoxic) cancer cells. J. Biomed. Nanotechnol. 11(7), 1162-1172 (2015). doi:10.1166/ jbn.2015.2067
35. Y. Aoyama, T. Kanamori, T. Nakai, T. Sasaki, S. Horiuchi, S. Sando, T. Niidome, Artificial viruses and their application to gene delivery. size-controlled gene coating with glycocluster nanoparticles. J. Am. Chem. Soc. 125(12), 3455-3457 (2003). doi:10.1021/ja029608t
36. S.-H. Wang, C.-W. Lee, A. Chiou, P.-K. Wei, Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J. Nanobiotechnol. 8(33), 1-13 (2010). doi:10.1186/1477-3155-8-33
37. H. Gao, W. Shi, L.B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U.S.A. 102(27), 9469-9474 (2005). doi:10.1073/pnas.0503879102
38. S. Zhang, J. Li, G. Lykotrafitis, G. Bao, S. Suresh, Size-dependent endocytosis of nanoparticles. Adv. Mater. 21(4), 419-424 (2009). doi:10.1002/adma.200801393
39. W. Chen, D.P. Cormode, Y. Vengrenyuk, B. Herranz, J.E. Feig, A. Klink, W.J. Mulder, E.A. Fisher, Z.A. Fayad, Collagenspecific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. JACC. Cardiovasc. Imaging 6(3), 373-384 (2013). doi:10.1016/j.jcmg.2012.06.016